AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
182 hedge funds and large institutions have $1.83B invested in Aerie Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 78 increasing their positions, 47 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1% more capital invested
Capital invested by funds: $1.81B → $1.83B (+$16.8M)
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
Holders
182
Holding in Top 10
7
Calls
$33.7M
Puts
$18M
Top Buyers
| 1 | +$75.4M | |
| 2 | +$41M | |
| 3 | +$32.3M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$13.5M |
| 5 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$13.2M |
Top Sellers
| 1 | -$19.1M | |
| 2 | -$18.2M | |
| 3 | -$16M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$15.7M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
-$12.1M |